Her2 expression can predict the survival of patients with salivary duct carcinoma
Salivary duct carcinoma (SDC) is a high-grade malignant tumor that mainly develops in the salivary glands, and SDC patients have a 5-year survival rate of less than 50%. Thirteen SDC patients (11 male and 2 female, average age 67.2 years) with primary salivary gland carcinoma who received primary tr...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Clinical Immunology Communications |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772613422000245 |